Meroë Psychiatric – Westport, Connecticut Ketamine Clinics, Spravato Clinics

✓ Last verified: January 15, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Meroë Psychiatric in Westport is a psychiatry practice founded by Dr. Frank S. K. Appah, who also serves as Unit Chief for the Psychiatric Inpatient Unit at St. Vincent’s Medical Centre in Bridgeport. The clinic is certified to administer Spravato™ (esketamine) nasal spray for treatment-resistant depression, combining ketamine-based treatment with weekly psychotherapy sessions. Dr. Appah’s dual role in both inpatient and outpatient psychiatric settings gives the practice deep clinical expertise in complex mental health cases.

HealingMaps Take: Meroë Psychiatric offers Spravato™ (esketamine) in a psychiatrist-led setting that emphasizes the therapy component alongside the medication. Dr. Appah’s experience as an inpatient psychiatric unit chief means he brings a level of clinical depth that’s uncommon in outpatient ketamine settings — particularly valuable for patients with complex or severe presentations. The Westport location serves Fairfield County’s affluent Gold Coast communities. While public reviews are limited, referrals from other therapists suggest positive clinical outcomes. Best suited for patients seeking FDA-approved esketamine with integrated psychotherapy rather than IV ketamine infusions.

Market Position: Meroë Psychiatric is a Spravato-certified clinic in the Westport metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.

Meroë Psychiatric Ketamine Cost Calculator

Ketamine Protocols Compared — What’s Offered at Meroë Psychiatric

Industry pricing reference. Meroë Psychiatric has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.

What to Expect at Your First Meroë Psychiatric Appointment

1. Initial intake call — Insurance verification, prior authorization workflow (Spravato requires documentation of failure on at least two antidepressant trials), and clinical eligibility check. Call (203) 528-0916 to schedule.
2. Medical evaluation — in-person or telehealth psychiatric assessment, vitals check, and review of current medications with the Meroë Psychiatric clinical team.
3. First treatment session — supervised Spravato (intranasal esketamine) in a private treatment room, lasting approximately 90 minutes (40-minute session + 60 minutes monitoring). Sessions are held at One Turkey Hill Road South, Suite 100, Westport, CT 06880. You’ll have a comfortable chair or recliner, dim lighting, and direct medical monitoring throughout.
4. Recovery and follow-up — observation period after dosing, mood check-in with the clinical team, and scheduling your next session. Arrange for a ride home; do not drive for 24 hours after your Spravato session.

What to Ask on Your Meroë Psychiatric Consult Call

• How long has the Meroë Psychiatric clinical team been delivering ketamine therapy, and what specialty training do your providers hold?
• How long does Meroë Psychiatric’s Spravato prior authorization typically take with my specific insurance plan, and what happens if it’s denied?
• Have you handled Anthem BCBS Connecticut, Cigna, or Aetna Spravato authorizations — and what’s the typical PA timeline?
• What does Meroë Psychiatric recommend for patients who don’t respond to the standard 6-session acute series?

Westport Ketamine Market Snapshot

Sources: CDC PLACES 2023 (Connecticut, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.

• Adult depression in Connecticut: N/A
• Frequent mental distress (14+ days per month): N/A
• Adults lacking health insurance: N/A
• Recent Westport-area inquiries to HealingMaps: A growing stream of Connecticut residents have recently contacted us seeking ketamine care

Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.

From the 2026 Ketamine Industry Report

Telehealth ketamine programs undercut in-clinic pricing by 40–60%, but 64.8% of surveyed patients still prefer supervised in-clinic treatment — a clear cost-vs-safety tradeoff patients should weigh before choosing an at-home program. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.

Patient Questions about Meroë Psychiatric

This 3-question summary is matched to the protocols and conditions Meroë Psychiatric treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.

Does Meroë Psychiatric offer Spravato (esketamine)?

Yes — Meroë Psychiatric offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.

Is Meroë Psychiatric suited for treatment-resistant depression?

Meroë Psychiatric treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.

Can Meroë Psychiatric help with anxiety disorders?

Yes — Meroë Psychiatric treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.

View all REMS-certified Spravato clinics in Connecticut and across the United States.

Location

Review (1)

• 
  Kane Peterson

  May 14, 2022 at 2:18 pm

  Hi Dr. Appah,
  I had contacted your office during the pandemic at the strong suggestion of Mel Schwartz. I spoke to Nurse Cherry and thought at that time I was alright to just continue talk therapy, but my lifelong depression has not lifted. I have since been taking Lexapro and doing cbt which has kept me afloat but barely. You have been suggested again to me by two therapists, Victoria Katz, who had a patient receive ketamine with you and who’s depression lifted, and Dr. Tom Smith, the head of the New York Psychiatric institute. I am informed by your service that you will not accept new patients. I cannot drive outside of Westport so I have no idea how I would handle getting to another Ketamine practitioner. In addition, my comfort level with anyone but you would be non existent.
  If you could possibly make an exception for me as hopefully I am already in your system I would be so very grateful.
  Thank you so much,
  Kane Peterson

  Helpful Review